Opdivo for Esophageal Carcinoma User Reviews
- Corey
- Taken for 1 to 6 months
- July 20, 2022
"Don’t take this drug it only causes harm. After 4 treatments it fried my thyroid and my adrenal gland’s. I’ve gone through hell for months as they try to adjust my medication. I will have to deal with this for the rest of my life. Your own immune system destroys your organs quickly."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Opdivo (nivolumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (85)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Stay away from this drug if you have esophageal cancer. It won’t work for you but will destroy any “itis” you might be susceptible to. It destroyed my husband’s thyroid and they could never get it back to normal with meds. After 9 infusions, by month 10 his esophageal cancer was back with a vengeance. Optivo does no good for esophageal patients. Just makes things worse."